Turk Ilac ve Serum Sanayi AS (TRILC) — Cash Flow Reinvestment Rate
Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow Reinvestment Rate of 4.39x as of September 2025, reinvesting TL195.46 Million (capex TL142.42 Million plus investments TL-53.05 Million) from operating cash flow of TL44.50 Million. Check Turk Ilac ve Serum Sanayi AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Turk Ilac ve Serum Sanayi AS Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Turk Ilac ve Serum Sanayi AS across 4 annual periods. Explore Turk Ilac ve Serum Sanayi AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Turk Ilac ve Serum Sanayi AS (2018–2023)
Year-by-year capital reinvestment analysis for Turk Ilac ve Serum Sanayi AS. For live market cap and broader valuation context, see TRILC market cap.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.56x | TL230.62 Million | TL408.19 Million | TL115.31 Million | ▼ -39.8% |
| 2020 | 0.94x | TL31.14 Million | TL33.20 Million | TL16.54 Million | ▼ -73.7% |
| 2019 | 3.56x | TL47.45 Million | TL13.32 Million | TL24.92 Million | ▲ +927.5% |
| 2018 | 0.35x | TL13.22 Million | TL38.13 Million | TL0.00 | — |